申请人:DIPHARMA FRANCIS S.r.l.
公开号:US20140205666A1
公开(公告)日:2014-07-24
Iminosugar, which possesses known activity as a glycosyltransferase inhibitor, and is used, for example, in the treatment of Gaucher's disease, in crystalline form, a process for its preparation and a pharmaceutical composition thereof.
Iminosugar是一种结晶形式的药物,具有已知的作为糖基转移酶抑制剂的活性,例如用于高尔基氏病的治疗。本发明还涉及一种制备上述药物的方法以及制备的药物组成物。